Emmyon

Emmyon is a biotechnology company that develops drugs by studying the effects of age, disease, and injury on muscle atrophy. The company specializes in skeletal muscle biology, metabolism, and small molecule discovery. Emmyon's patent-protected technology portfolio includes natural dietary compounds such as ursolic acid and tomatidine, as well as novel compounds. Our natural compounds are being developed as dietary supplements and functional foods to help maintain normal muscle mass, strength, mobility, healthy metabolism, healthy aging, and a non-obese/muscular body composition. Our novel compounds are being developed as treatments for muscle atrophy, obesity, and type 2 diabetes.